高级检索
当前位置: 首页 > 详情页

Metabolic syndrome and chronic kidney disease in general Chinese adults: Results from the 2007-08 China National Diabetes and Metabolic Disorders Study

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Peoples R China [2]Hubei Univ Arts & Sci, Affiliated Hosp, Xiangyang Ctr Hosp, Dept Oncol, Xiangyang, Peoples R China [3]Fourth Mil Med Univ, Sch Prevent Med, Dept Hlth Stat, Xian 710032, Peoples R China [4]Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales [5]China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China
出处:
ISSN:

关键词: Metabolic syndrome Chronic kidney disease Chinese adults Epidemiology and outcomes

摘要:
Background: China is undergoing a rapid transition to an urbanized and Western diet pattern, which worsens the public health burden of metabolic syndrome (MS) and chronic kidney disease (CKD). We aimed to estimate the prevalence of CKD among adults with MS and to evaluate the association between MS and CKD in China. Methods: The data were obtained from the China National Diabetes and Metabolic Disorders Study conducted from June 2007 to May 2008.A total of 15,987 individuals aged 20 y or older were included as study participants. Results: Age-standardized prevalence of CKD, which was defined as a glomerular filtration rate <60 ml/min/1.73 m(2), in participants with and without MS was 4.64% and 3.30%, respectively. The multivariate-adjusted odds ratio of CKD associated with MS was 1.495 (95% Cl: 1.190-1.879). Elevated blood pressure, elevated fasting glucose, elevated triglycerides, and reduced high-density lipoprotein cholesterol had statistically significant increased odds ratios of 1.218, 1.256, 1.325 and 1.797 for CKD, respectively, while elevated waist circumference was not significantly associated with an increased odds ratio of CKD. Conclusions: Our study suggests an increasing prevalence of CKD among Chinese adults with MS and a strong association between CKD and MS. (C) 2014 The Authors. Published by Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2013]版:
大类 | 3 区 医学
小类 | 2 区 医学实验技术
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 医学实验技术
JCR分区:
出版当年[2012]版:
Q1 MEDICAL LABORATORY TECHNOLOGY
最新[2023]版:
Q2 MEDICAL LABORATORY TECHNOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2012版] 出版当年五年平均[2008-2012] 出版前一年[2011版] 出版后一年[2013版]

第一作者:
第一作者单位: [1]Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, Xian 710032, Peoples R China
通讯作者:
通讯机构: [5]China Japan Friendship Hosp, Dept Endocrinol, Beijing 100029, Peoples R China [*1]Fourth Mil Med Univ, Xijing Hosp, Dept Endocrinol, 169 Changle Rd West, Xian 710032, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)